Current Concepts on Anti-Phospholipase A2 Receptor Antibody in Idiopathic Membranous Nephropathy
Abstract
LETTER TO THE EDITOR
1. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS.Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One 2013; 8(4):e62151.
2. Seif EI, Ibrahim EA, El hefnawy NG, Salman MI.Histological patterns of idiopathic steroid resistant nephrotic syndrome in Egyptian children: A single centre study. J Nephropathol 2013; 2(1):53-60.
3. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003;23(4):324-32.
4. Nasri H, Ardalan MR. Significance of hyperuricemia in immunoglobulin A nephropathy. J Ren Inj Prev 2013;2(3): 105-106.
5. Murtas C, Ravani P, Ghiggeri GM. New insights into membranous glomerulonephritis: from bench to bedside. Nephrol Dial Transplant 2011; 26(8):2428-30.
6. Rolla D, Bellino D, Peloso GC, Rastaldi MP, Simonini P, Ravetti. The first case of IgG4-related disease in Italy. J Nephropathol 2013; 2(2):144-9.
7. Stone JH. IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease. Kidney Int 2013; 83(3):348-50.
8. Nasri H. Antiphospholipid syndrome-associated nephropathy: Current concepts. J Ren Inj Prev 2013; 2(1): 1-2.
9. Nasri H, Mubarak M. Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease. J Ren Inj Prev 2013; 2(3):107-8.
10. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol 2012; 1(3):162-3.
11. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361(1):11–21.
12. Ardalan MR, Ghafari A, Hamzavi F, Nasri H, Baradaran B, Majidi J. Antiphospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population. J Nephropathol 2013; 2(4):241-8.
13. Lv J, Hou W, Zhou X, Liu G, Zhou F, Zhao N,et al.Interaction between PLA2R1 and HLA-DQA1 Variants Associates with Anti-PLA2R Antibodies and Membranous Nephropathy. J Am Soc Nephrol 2013;24(8):1323-9.
14. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361(1):11-21.
15. Nayer A, Asif A. Idiopathic membranous nephropathy and anti-phospholipase A2 receptor antibodies. J Nephropathol 2013; 2(4): 214-6.
16. Malleshappa P. C1q nephropathy- unity in diversity. J Ren Inj Prev 2013; 2(4): 117-118.
17. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A₂ receptor antibodies correlate
with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6(6):1286-91.
18. Nasri H, Mubarak M. Sudden deterioration of renal function in a patient with nephrotic syndrome and a very high hepatitis B viral DNA load. J Ren Inj Prev 2012;1(1):39-41.
19. Debiec H, Martin L, Jouanneau C, Dautin G, Mesnard L, Rondeau E, et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am J Transplant 2011;11(10):2144-52.
20. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K. Anti- phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011; 22(6):1137-43.
| Files | ||
| Issue | Vol 13, No 2 (2014) | |
| Section | Articles | |
| Keywords | ||
| Membranous nephropathy Nephrotic syndrome Phospholipase A2 receptor | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
